About Interpore International
Synthetic bone graft material for the orthopaedic, oral, and maxillofacial markets. The company's synthetic bone graft products are derived from coral using its proprietary manufacturing process, which converts the unique skeletal structures of certain species of coral to coralline hydroxyapatite, a biocompatible material. Coralline hydroxyapatite has interconnected porosity, architecture and chemical composition similar to that of human cancellous bone, and facilitates bone and tissue ingrowth. The company also distributes a titanium dental implant system for the rehabilitation of partially and totally toothless patients. In November 1992, the company received FDA approval to market its synthetic bone graft material Pro Osteon Implant 500 Coralline Hydroxyapatite Bone Void Filler for the repair of acute metaphyseal defects in conjunction with rigid internal fixation as dictated by the clinical use requirements in skeletally mature individuals when there is no autogenous bone donor site available.